Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Analyzing the Decline in BMNR Stock Prices

This morning we watched Series drop -3.1% to a price of $52.14 per share. The Large-Cap Diversified Financial company is now trading -30.48% below its average target price of $75.0. Analysts have set target prices ranging from $60.0 to $90.0 per share for Series, and have given the stock an average rating of buy.

The stock has an above average percentage of its shares sold short at 10.2%, and a short ratio of 0.36. The company's insiders own 3.63% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a very small number of institutional investors are invested in the stock, with 7.2% of Series's shares being owned by this investor type.

Institutions Invested in Series

Date Reported Holder Percentage Shares Value
2025-09-30 Strong Tower Advisory Services 1% 276,412 $14,409,357
2025-09-30 Halter Ferguson Financial Inc. 1% 217,953 $11,361,890
2025-09-30 Oriental Harbor Investment Master Fund 0% 185,869 $9,689,351
2025-06-30 Scientech Research LLC 0% 74,557 $3,886,656
2025-06-30 Schonfeld Strategic Advisors Llc 0% 51,764 $2,698,457
2025-06-30 Sassicaia Capital Advisers, LLC 0% 46,309 $2,414,088
2025-09-30 Voya Investment Management LLC 0% 44,813 $2,336,101
2025-09-30 Lauer Wealth, LLC 0% 32,620 $1,700,480
2025-06-30 Morgan Stanley 0% 27,485 $1,432,793
2025-09-30 Generali Investments Cee, Investicni Spolecnost, A.s. 0% 23,000 $1,198,990

Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on Series.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS